We are proud to announce we have acquired our first few shares of $AEMD as per the communities request.
Reflections will be updated on the website shortly.
We are proud to announce we have acquired our first few shares of $AEMD as per the communities request.
Reflections will be updated on the website shortly.
$AEMD still in the lead.
https://t.co/ZIbKWkfcdE
They've recently had a $50m in financing after having reported a narrow net loss in their first quarter.
Why?
Huge up-side potential in clinical-stage medtech research, an extremely low cap stock taking into consideration its external funding amount.
In simple terms: yes
That is the main overall idea of Hound.
Become the biggest shareholder in low cap NASDAQ-listed companies -> Acquisition -> On-chain tokenization of the company -> Company revenue flows back into the protocol.
It's an ambitious project, but really no limit to what we can achieve.